Eylea (aflibercept) is used for certain eye conditions related to the retina (a layer of cells in the back of the eye) for both adults and premature babies. It's typically injected into the eye by an eye specialist. Eylea (aflibercept) is only available at specialty pharmacies or distributors, so a provider will help you set that up.
Eylea (aflibercept) is a vascular endothelial growth factor (VEGF) inhibitor. It blocks VEGF, a protein that makes new blood vessels in the body. When there's too much of these proteins in the eye, it creates new, weak blood vessels which leak fluid into the back of the eye.
By blocking VEGF proteins from working, Eylea (aflibercept) slows the growth of additional blood vessels to lessen the amount of fluid leaking in the eye. So it helps to lower the risk of vision loss in different eye conditions.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Adults
Children
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Studies showed that Eylea (aflibercept) helps people with wet AMD see nearly two more rows of letters on an eye chart. This medication has also helped 94% of people in clinical studies with wet AMD maintain their vision for more than a year. If you have any questions about whether Eylea (aflibercept) is right for you, follow up with your provider for more information.
No, Eylea (aflibercept) isn't a cure for DR. Currently, all available treatments or medications for DR can only slow down or stop your vision from getting worse. Eylea (aflibercept) can slow down the progression of DR. In one study, about 80% of people who received Eylea (aflibercept) for a year had less serious DR compared to only 15% of people who didn't receive this medication. Ask your provider if you have more questions about DR and its treatment.
Eylea (aflibercept) and similar medications like Beovu (brolucizumab), Lucentis (ranibizumab), and Avastin (bevacizumab) are all used to treat wet AMD. They are all VEGF inhibitors, meaning they work similarly. Avastin (bevacizumab) was originally approved to treat cancer, but many eye specialists are using it off-label to treat wet AMD. Although there are slight differences in how often you receive the medication, there aren't that many differences between them. You just might respond better to one medication versus another. Talk with your provider to determine which medication is best for you.
Maybe. Studies showed that some people with eye problems that got Eylea (aflibercept) developed blood clot problems, including heart attack and stroke. While the risk is low, it's important to look out for life-threatening side effects related to blood clots. Get medical attention right away if you have symptoms of a stroke (sudden confusion, severe headache, facial drooping, weakness on one side of the body, slurred speech, or trouble walking) or a heart attack (chest pain that travels to your arm or jaw, sweating, or shortness of breath). Discuss with your provider the risks versus benefits of using this medication if you've had a history of heart attack or stroke.
Eylea (aflibercept) hasn’t been studied in pregnant people, but animal studies showed that this medication caused birth defects in baby animals. If you're female who can get pregnant, make sure to use birth control, like condoms, before the first injection of Eylea (aflibercept), during treatment, and for at least 3 months after you stop. If you’re pregnant or planning on becoming pregnant, talk to your provider so you can discuss the risks of receiving Eylea (aflibercept).
Eylea (aflibercept) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Very rarely, eye injections, such as Eylea (aflibercept), can lead to endophthalmitis (infection of the tissues or fluids inside the eyeball) or detached retina (when the retina pulls away from the back of the eye). This can sometimes happen when the eye gets contaminated or infected during the injection. Your or your child's healthcare provider might provide a topical antibiotic beforehand to lower the risk of infection. They will also have the proper techniques and tools to lower the risk of contamination during the procedure. Make sure to follow up with the provider after your or your child's appointment to monitor for any visual changes. If your or your child's eye becomes red, sensitive to light, painful, or develops a change in vision, let the provider know right away.
People who receive Eylea (aflibercept) can sometimes experience higher eye pressure because there's more fluid in the eye due to the injection. This is usually temporary and typically happens within an hour after the injection. The risk is higher in people who get regular eye injections. You or your child will need to get eye pressure checked each time after receiving Eylea (aflibercept) so the provider can make sure this medication continues to be safe. If you or your child experiences intense eye pain, nausea, red eye, and blurry vision after receiving Eylea (aflibercept), talk with the provider immediately.
Eylea (aflibercept) injections might cause serious blood clot problems, such as heart attack and stroke. Symptoms of a stroke include sudden confusion, severe headache, facial drooping, weakness on one side of the body, slurred speech, or trouble walking. Symptoms of a heart attack include chest pain that travels to your arm or jaw, sweating, or shortness of breath. If you have symptoms of a stroke or heart attack, get medical help right away.
The dose of Eylea (aflibercept) depends on the condition being treated. In general:
Adults
Children
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Eylea (aflibercept) will not be safe for you to take.
Conditions related to swelling or damage to the macula or retina (parts of the eye that are important for vision):
Lucentis and all its biosimilars
Lucentis and Cimerli biosimilar only